Ironwood Investment Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.7M | Sell |
62,446
-2,056
| -3% | -$88.8K | 1.31% | 16 |
|
|
2025
Q1 | $2.23M | Buy |
64,502
+1,345
| +2% | +$46.5K | 1.22% | 22 |
|
|
2024
Q4 | $1.73M | Buy |
63,157
+338
| +0.5% | +$9.28K | 0.86% | 30 |
|
|
2024
Q3 | $1.6M | Sell |
62,819
-185
| -0.3% | -$4.71K | 0.78% | 38 |
|
|
2024
Q2 | $1.6M | Sell |
63,004
-47
| -0.1% | -$1.19K | 0.85% | 34 |
|
|
2024
Q1 | $1.95M | Sell |
63,051
-1,453
| -2% | -$44.9K | 0.95% | 31 |
|
|
2023
Q4 | $2.6M | Sell |
64,504
-33
| -0.1% | -$1.33K | 1.37% | 18 |
|
|
2023
Q3 | $1.7M | Sell |
64,537
-1,826
| -3% | -$48.2K | 1.04% | 28 |
|
|
2023
Q2 | $1.14M | Sell |
66,363
-2,500
| -4% | -$43K | 0.66% | 47 |
|
|
2023
Q1 | $1.14M | Buy |
68,863
+620
| +0.9% | +$10.3K | 0.71% | 47 |
|
|
2022
Q4 | $520K | Sell |
68,243
-3,723
| -5% | -$28.4K | 0.34% | 91 |
|
|
2022
Q3 | $715K | Buy |
71,966
+82
| +0.1% | +$815 | 0.5% | 72 |
|
|
2022
Q2 | $653K | Buy |
71,884
+55
| +0.1% | +$500 | 0.44% | 83 |
|
|
2022
Q1 | $729K | Buy |
71,829
+1,770
| +3% | +$18K | 0.4% | 89 |
|
|
2021
Q4 | $1.17M | Buy |
70,059
+44,740
| +177% | +$747K | 0.58% | 56 |
|
|
2021
Q3 | $1.19M | Sell |
25,319
-26
| -0.1% | -$1.22K | 0.62% | 52 |
|
|
2021
Q2 | $1.55M | Sell |
25,345
-494
| -2% | -$30.1K | 0.78% | 37 |
|
|
2021
Q1 | $1.59M | Buy |
25,839
+158
| +0.6% | +$9.74K | 0.84% | 29 |
|
|
2020
Q4 | $1.83M | Sell |
25,681
-607
| -2% | -$43.2K | 1.07% | 23 |
|
|
2020
Q3 | $986K | Sell |
26,288
-46
| -0.2% | -$1.73K | 0.7% | 41 |
|
|
2020
Q2 | $859K | Buy |
26,334
+3,924
| +18% | +$128K | 0.67% | 52 |
|
|
2020
Q1 | $650K | Buy |
+22,410
| New | +$650K | 0.65% | 54 |
|